News

The Safety and Tolerability of An RNAi Therapeutic in Familial Adenomatous Polyposis (START-FAP) trial will begin enrolling patients in the next several weeks at Massachusetts General Hospital (MGH)

As per the agreement, Spectrum will have all rights related to marketing, sales, and patents, and access to existing inventory of ZEVALIN from Bayer. The Merchant Banking Group

The agreement is aimed at delivering drug development candidates directed to a key respiratory target of interest to Almirall. As per the collaboration, BioFocus will apply its integrated

The suite of solutions included irms|WM Warehouse Management and irms|EM Emergency Management, providing real-time visibility and accurate tracking of critical emergency supplies, people and processes. irms|WM facilitates a

The alliance between the two companies focused on development of molecules for a range of therapeutic areas, economictimes.indiatimes.com reported. Jubilant Life Sciences’ wholly-owned subsidiary Jubilant Biosys has entered

The designation will allow frequent interactions with the FDA during the drug development process, which assures that questions and issues are resolved quickly. VMAT2 is a protein concentrated

As per the agreement, Watson acquired Ascent Pharmahealth for AU$375 million (approximately $393 million) in cash. Watson expects the deal to be immediately accretive to 2012 non-GAAP earnings.

The patent is related to methods and techniques that facilitate discovery of biomarkers and aid in the development of predictive and prognostic diagnostic tests for therapeutics targeting complex

The new machine is compact and integrated, delivering high output while ensuring maximum product safety and highly convenient operation, according to Healthcarepackaging. The TTP’s rotary system will save